tutacache.blogg.se

individuals 18 through 64 years of age at high risk of severe COVID-19 and.

Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series in:

For Immediate Release: September 22, 2021